GlassScriptPhysician profile
Tamara Lynn Hoffman
NPI 1700838687
$15,567.25
in general payments reported to CMS, 2019-2025
61 companies · $1,860 in 2025
The $1,860 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,252 · 2020: $2,007 · 2021: $2,517 · 2022: $2,403 · 2023: $2,366 · 2024: $2,163 · 2025: $1,860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,388.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,686.59 | 2019-2025 | |
| Novo Nordisk INC | $1,627.86 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $1,120.10 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,002.21 | 2019-2025 | Farxiga, Lokelma, Breztri |
| Amarin Pharma, INC. | $913.06 | 2019-2023 | |
| Glaxosmithkline, LLC. | $744.80 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $689.67 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $630.69 | 2019-2025 | Krystexxa, Repatha, Otezla |
| E.R. Squibb & Sons, L.L.C. | $523.85 | 2020-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $515.25 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $506.25 | 2019-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $477.15 | 2019-2025 | Verquvo, Belsomra, Capvaxive |
| Astellas Pharma US INC | $382.32 | 2019-2024 | Myrbetriq, Veozah |
| Novartis Pharmaceuticals Corporation | $288.16 | 2019-2024 | |
| Allergan, INC. | $286.62 | 2019-2020 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $253.26 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Daiichi Sankyo INC. | $224.20 | 2020-2023 | Injectafer |
| Sanofi-Aventis U.S. LLC | $211.70 | 2019-2025 | |
| Aimmune Therapeutics, INC. | $207.96 | 2024-2025 | Zenpep |
| Biohaven Pharmaceutical Holding Company LTD. | $199.86 | 2022 | |
| Phathom Pharmaceuticals, INC. | $192.07 | 2024-2025 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.99 | 2019-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $173.46 | 2023-2025 | Rexulti, Nuedexta |
| Horizon Therapeutics Plc | $167.89 | 2019-2022 | |
| Abbott Laboratories | $162.45 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Kowa Pharmaceuticals America, INC. | $157.23 | 2019-2023 | Livalo, Seglentis |
| Lundbeck LLC | $149.20 | 2023-2025 | Rexulti, Vyepti |
| Esperion Therapeutics, INC. | $145.45 | 2021 | |
| Boston Scientific Corporation | $144.62 | 2019-2025 | Watchman Flx |
| Tactile Systems Technology INC | $122.16 | 2022-2025 | Nimbl, Flexitouch Plus |
| Biogen, INC. | $103.64 | 2021-2022 | |
| Axsome Therapeutics, INC. | $95.83 | 2024-2025 | Symbravo, Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $95.00 | 2021-2023 | |
| Eisai INC. | $90.58 | 2020-2024 | |
| Verona Pharma, INC. | $85.92 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $85.36 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $77.62 | 2019 | |
| Stryker Corporation | $77.13 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Electromed, INC. | $71.58 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $70.61 | 2019 | |
| Dexcom, INC. | $63.24 | 2021-2023 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $56.24 | 2019-2021 | |
| Corcept Therapeutics | $51.99 | 2020-2021 | |
| Inari Medical, INC. | $51.09 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biohaven Pharmaceuticals, INC. | $46.47 | 2021 | |
| Ardelyx, INC. | $45.02 | 2025 | Ibsrela |
| Teva Pharmaceuticals USA, INC. | $35.43 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $29.88 | 2023 | |
| Alnylam Pharmaceuticals INC. | $26.98 | 2025 | Onpattro |
| Ironwood Pharmaceuticals, INC | $23.89 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $23.49 | 2022 | |
| Neurocrine Biosciences, INC. | $23.08 | 2025 | |
| Ani Pharmaceuticals, INC. | $20.82 | 2024 | Purified Cortrophin Gel |
| Genentech USA, INC. | $18.69 | 2019 | |
| Amneal Pharmaceuticals LLC | $17.35 | 2025 | Unithroid |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $17.14 | 2025 | Rexulti |
| Shire North American Group INC | $16.18 | 2019 | |
| Idorsia Pharmaceuticals US INC | $15.98 | 2022 | |
| Paratek Pharmaceuticals, INC. | $13.31 | 2022 | |
| Philips North America LLC | $12.63 | 2020 | |
| Bardy Diagnostics, INC. | $8.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.